Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 34,800
+1,450 (4.35%)
At close: Oct 2, 2025
4.35% (1Y)
| Market Cap | 1.75T |
| Revenue (ttm) | 150.09B |
| Net Income (ttm) | 2.23B |
| Shares Out | 50.75M |
| EPS (ttm) | 44.00 |
| PE Ratio | 784.06 |
| Forward PE | 313.62 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 668,440 |
| Average Volume | 350,207 |
| Open | 33,500 |
| Previous Close | 33,350 |
| Day's Range | 33,200 - 35,200 |
| 52-Week Range | 24,000 - 52,000 |
| Beta | 0.82 |
| RSI | 64.55 |
| Earnings Date | Nov 14, 2025 |